Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions

International Journal of Gynecological Pathology

Volumn 26, Issue 3, 2007, Pages 214-222

  Saha, Baisakhi ^a   Chaiwun, Benjaporn ^b   Tsao Wei, Denice D ^c   Groshen, Susan L ^c   Naritoku, Wesley Y ^c   Atkinson, Roscoe D ^d   Taylor, Clive R ^c   Imam, S Ashraf ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Clarient Inc   (United States)

Author keywords

Cervical premalignant lesions; hTERT; Immunohistochemical staining; Telomerase

Indexed keywords

BIOLOGICAL MARKER; DNA TOPOISOMERASE (ATP HYDROLYSING); KI 67 ANTIGEN; PROTEIN SUBUNIT; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CATALYSIS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; EPITHELIUM CELL; FEMALE; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX MUCOSA;

ANTIGENS, NEOPLASM; CELL GROWTH PROCESSES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; RETROSPECTIVE STUDIES; STROMAL CELLS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 34250867496     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000250146.44592.d2     Document Type: Article

References (35)

1. Dyson N, Howely PM, Munger K, et al. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-7.
2. Hubbert NL, Sedman SA, Schiller JT. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol 1992;66:6237-41.
3. Cooper K, McGee JO. Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective. Mol Pathol 1997;50:1-3.
4. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
5. Van Duin M, Steenbergen RD, de Wilde J, et al. Telomerase activity in high-grade cervical lesions is associated with imbalance at 6Q14-22. Int J Cancer 2003;105:577-82.
6. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
7. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
8. Bryce LA, Morrison N, Hoare SF, et al. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2000;2:197-201.
9. Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science 1997;275:973-7.
10. Ulaner GA, Hu JF, Vu TH, et al. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998;58:4168-72.
11. Hahn WC, Counter CM, Lundberg AS, et al. Creation of human tumour cells with defined genetic elements. Nature 1999;400:464-8.
12. Yashima K, Ashfaq R, Nowak J, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998;82:1319-27.
13. Pao CC, Tseng CJ, Lin CY, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997;15:1932-7.
14. Wisman GB, De Jong S, Meersma GJ, et al. Telomerase in (pre)neoplastic cervical disease. Hum Pathol 2000;31:1304-12.
15. Jarboe EA, Liaw KL, Thompson LC, et al. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 2002;21:664-73.
16. Hiyama E, Hiyama K, Yokoyama T, et al. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001;3:17-26.
17. Tahara H, Yasui W, Tahara E, et al. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor issue sections. Oncogene 1999;18:1561-7.
18. Kawakami Y, Kitamoto M, Nakanishi T, et al. Immunohistochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 2000;19:3888-93.
19. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998;58:1558-61.
20. Frost M, Bobak JB, Gianani R, et al. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia and squamous carcinoma of the cervix. Am J Clin Pathol 2000;114:726-34.
21. Baltayan A, Naritoku WY, Chaiwun B, et al. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Anticancer Res 2002;22:2233-7.
22. Bauer KD, de la Torre-Bueno J, Diel IJ, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000;6:3552-9.
23. Wang S, Saboorian MH, Frenkel EP, et al. Assessment of Her-2/neu status in breast cancer: automated cellular imaging system (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol 2001;116:495-503.
24. Pierga J-Y, Bonneton C, Vincent-Salomon A, et al. Clinical significance of immunohistochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004;10:1392-1400.
25. Mehta CR, Patel NR. A network algorithm for performing Fisher exact test in contingency tables. J Am Stat Assoc 1983;78:427-34.
26. Nakayama K, Ishikawa J, Tahara E, et al. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor or non tumor tissue sections. Oncogene 1999;18:1561-7.
27. Weng NP. Regulation of telomerase expression in human lymphocytes. Springer Semin Immunopathol 2002;24:23-33.
28. Martens JE, Arends J, Van der Linden PJ, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res 2004;:771-5.
29. Davidson B, Goldberg I, Lerner-Geva L, et al. Expression of topoisomerase II and Ki-67 in cervical carcinoma - clinicopathological study using immunohistochemistry. APMIS 2000;108:209-15.
30. Smith DL, Soria JC, Morat L, et al. Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 2004;11:45-51.
31. Fujita Y, Fujikane T, Fujiuchi S, et al. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma. Cancer 2003;98:1008-13.
32. Elder EE, Xu D, Hoog A, et al. Ki-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol 2003;16:246-55.
33. Brustmann H. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase II alpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia. Int J Gynecol Pathol 2005;24:184-92.
34. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998;58:3812-8.
35. Mutirangura A, Sriuranpong V, Termrunggraunglert W, et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions. Br J Cancer 1998;78:933-9.